Serum and intracellular magnesium deficiency in patients with metabolic syndrome—Evidences for its relation to insulin resistance

Published:January 05, 2009DOI:https://doi.org/10.1016/j.diabres.2008.11.019

      Abstract

      This cross sectional study evaluated serum (SMg) and intramononuclear (MMg) magnesium in patients with metabolic syndrome without diabetes and correlated them with cardiovascular risk factors. 72 patients and 57 controls (blood donors) were studied. Hypomagnesemia (SMg < 1.7 mg/dL) was seen in 23.2% and intracellular depletion in 36.1% of the patients. SMg and MMg means were significantly lower in patients than in controls: 1.80 ± 0.18 mg/dL vs. 2.43 ± 0.43 mg/dL and 0.98 ± 0.55 μg/mg vs. 1.67 ± 0.64 μg/mg of protein (P < 0.001). Inverse correlation was observed between, SMg and MMg with BMI; SMg with systolic blood pressure and waist circumference in women. Patients with acanthosis nigricans had lower SMg (1.75 ± 0.18 mg/dL vs. 1.85± 0.18 mg/dL, P < 0.05). Non-white people had lower SMg (1.78 ± 0.16 mg/dL vs. 1.92 ± 0.24 mg/dL, P = 0.007) and MMg (0.95 ± 0.59 μg/mg vs. 1.13 ± 0.42 μg/mg, P = 0.03). Patients with IR showed lower MgM means (0.84 ± 0.33 μg/mg vs. 1.14 ± 0.69 μg/mg, P < 0.05). The same occurred in patients with low HDL-c levels (0.92 ± 0.46 μg/mg vs. 1.20 ± 0.70 μg/mg, P = 0.03), and those with moderate and severe hepatic steatosis (0.77 ± 0.29 μg/mg vs. 1.21 ± 0.80 μg/mg, P < 0.05). In conclusion, magnesium depletion in serum and mononuclear cells is common in obese people with metabolic syndrome, and it is more evident in non-white people with insulin resistance. This depletion may contribute to a post-receptor insulin resistance.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Elin R.J.
        Magnesium metabolism in health and disease.
        Dis. Mon. 1998; 4: 163-208
        • Paolisso G.
        • Scheen A.
        • D’Onofrio F.
        • Lefèbvre P.
        Magnesium and glucose homeostasis.
        Diabetologia. 1990; 33: 511-514
        • Reinhart R.
        Magnesium metabolism.
        Arch. Intern. Med. 1998; 148: 2415-2420
        • Wills M.
        • Sunderman F.
        • Savory J.
        Methods for the estimation of serum magnesium in clinical laboratories.
        Magnesium. 1986; 5: 317-327
        • Rude R.
        • Singer F.
        Magnesium deficiency and excess.
        Annu. Rev. Med. 1981; 32: 245-259
        • Mather H.
        • Nisbet J.A.
        • Burton G.H.
        • Poston G.J.
        • Bland J.M.
        • Bailey P.A.
        • et al.
        Hypomagneseamia in diabetes.
        Clín. Chim. Acta. 1979; 95: 235-242
        • Lima M.L.
        • Cruz T.
        • Pousada J.C.
        • Barbosa K.
        • Canguçu V.
        The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes.
        Diabetes Care. 1998; 21: 682-686
        • Kao W.H.
        • Folsoma R.
        • Nieto F.J.
        • Brancati F.L.
        Serum and dietary magnesium and the risk of type 2 diabetes mellitus and atherosclerosis risk in community study.
        Arch. Intern. Med. 1999; 159: 2151-2159
        • Song Y.
        • Ridker P.M.
        • Manson J.E.
        • Cook N.R.
        • Buring J.E.
        • Liu S.
        Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older US women.
        Diabetes Care. 2005; 28: 1438-1444
        • Ford E.S.
        • Giles W.H.
        • Dietz W.H.
        Prevalence of the metabolic syndrome among US adults. Findings from the third NHANES.
        JAMA. 2002; 287: 356-359
        • Grundy S.M.
        • Cleeman J.I.
        • Daniels S.R.
        • Donato K.A.
        • Eckel R.H.
        • Franklin B.A.
        • et al.
        Diagnosis and management of the metabolic syndrome.
        Circulation. 2005; 112: 2735-2752
        • Barbagallo M.
        • Dominguez L.J.
        • Galioto A.
        • Ferlisi A.
        • Cani C.
        • Malfa L.
        • et al.
        Role of Magnesium in insulin action, diabetes and cardio-metabolic syndrome X.
        Mol. Aspects Med. 2003; 24: 39-52
        • Alberti K.
        • Zimmet P.
        • Shaw J.
        The metabolic syndrome. A new worldwide definition.
        Lancet. 2005; 366: 1059-1062
        • Mathews D.R.
        • Hosker J.P.
        • Rudenski A.S.
        • Naylor B.A.
        • Treacher D.F.
        • Turner R.C.
        Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man.
        Diabetologia. 1985; 28: 412-419
        • Gelloneze B.
        • Repetto E.M.
        • Geloneze S.
        • Ermetice M.N.
        • Tambascia M.A.
        The threshold value for insulin resistance (HOMA-IR). IR in the Brazilian metabolic syndrome study.
        Diabetes Res. Clin. Pract. 2006; 72: 219-229
        • Rodrigues L.E.A.
        • Mathias C.M.C.
        • Amorim M.S.P.
        Modificação do método de Lowry para a quantificação de proteínas.
        Rev. Bras. Pato.l Clin. 1989; 25: 1-11
        • Yanai H.
        • Morimoto M.
        Diagnosis of non alcoholic fat liver disease.
        JAMA. 2003; 290: 1577
        • Guerrero-Romero F.
        • Rodríguez-Morán M.
        Low serum magnesium levels and metabolic síndrome.
        Acta Diabetol. 2002; 39: 209-213
        • Randell R.
        • Mathews M.
        • Dadag V.
        • Zhang H.
        • Sun G.
        Relationship between serum magnesium values, lipid and anthropometrics risk factors.
        Atherosclerosis. 2006; 196: 413-419
        • Huerta M.G.
        • Roemmich J.N.
        • Kington M.L.
        • Bovbjerg V.E.
        • Weltman A.L.
        • Holmes V.F.
        • et al.
        Magnesium deficiency is associated with insulin resistance in obese children.
        Diabetes Care. 2005; 28: 175-181
        • Faintuch J.J.
        Aspectos do metabolismo do magnésio no Brasil.
        Rev. Bras. Med. 1991; 48: 533-540
        • Djurhuus M.S.
        • Skǿtt P.
        • Hother-Nielson O.
        • Klitgaard N.A.
        • Beck-Nielsen H.
        Insulin increases renal magnesium excretion: a possible cause of magnesium depletion in hiperinsulinemic states.
        Diabet. Med. 1995; 12: 664-669
        • Paolisso G.
        • Sgambatto S.
        • Passariello N.
        • Giugliano D.
        • Scheen A.
        • D’Onofrio F.
        • et al.
        Insulin induces opposite changes in plasma and erythrocyte magnesium concentration in normal man.
        Diabetologia. 1986; 29: 644-647
        • Hwang D.L.
        • Yan C.F.
        • Nadles J.L.
        Insulin increases intracellular magnesium transport in human platelets.
        J. Clin. Endocrinol. Metab. 1993; 76: 549-553
        • Guerrero-Romero F.
        • Rodríguez-Morán M.
        Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values.
        J Diabetes Complications. 2000; 14: 272-276
        • Rodriguez-Hernandez H.
        • Gonzalez J.L.
        • Rodriguez-Moran M.
        • Guerrero-Romero F.
        Hypomagnesemia, insulin resistance, and non-alcoholic steatohepatitis.
        Arch. Med. Res. 2005; 36: 362-366
        • Ma B.
        • Lawson B.L.
        • Liese A.D.
        • Bell R.A.
        • Mayer-Davis E.J.
        Dairy, magnesium, and calcium intake in relation to insulin sensitivity: approaches to modeling a dose dependent association.
        Am. J. Epidemiol. 2006; 164: 449-458
        • He K.
        • Liou K.
        • Rodrigues M.L.
        • Loria C.M.
        • Van Horn L.
        • Jacobs D.R.
        • et al.
        Magnesium intake and incidence of metabolic syndrome among young adults.
        Circulation. 2006; 196: 413-419
        • Rayssiguier Y.
        • Guex E.
        • Nowacki W.
        • Rock E.
        • Mazur A.
        High fructose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation.
        Magnes. Res. 2006; 19: 237-243